Outlook Therapeutics Inc Stock Price Patterns
| OTLK Stock | USD 0.42 0.02 5.00% |
Momentum 27
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.21) | EPS Estimate Current Year (0.67) | EPS Estimate Next Year (0.41) | Wall Street Target Price 5.375 | EPS Estimate Current Quarter (0.25) |
Using OUTLOOK THERAPEUTICS hype-based prediction, you can estimate the value of OUTLOOK THERAPEUTICS INC from the perspective of OUTLOOK THERAPEUTICS response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards OUTLOOK THERAPEUTICS using OUTLOOK THERAPEUTICS's stock options and short interest. It helps to benchmark the overall future attitude of investors towards OUTLOOK using crowd psychology based on the activity and movement of OUTLOOK THERAPEUTICS's stock price.
OUTLOOK THERAPEUTICS Short Interest
An investor who is long OUTLOOK THERAPEUTICS may also wish to track short interest. As short interest increases, investors should be becoming more worried about OUTLOOK THERAPEUTICS and may potentially protect profits, hedge OUTLOOK THERAPEUTICS with its derivative instruments, or be ready for some potential downside.
200 Day MA 1.5188 | Short Percent 0.0619 | Short Ratio 0.39 | Shares Short Prior Month 9.1 M | 50 Day MA 1.206 |
OUTLOOK THERAPEUTICS INC Hype to Price Pattern
Investor biases related to OUTLOOK THERAPEUTICS's public news can be used to forecast risks associated with an investment in OUTLOOK. The trend in average sentiment can be used to explain how an investor holding OUTLOOK can time the market purely based on public headlines and social activities around OUTLOOK THERAPEUTICS INC. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of OUTLOOK THERAPEUTICS's market sentiment to its price can help taders to make decisions based on the overall investors consensus about OUTLOOK THERAPEUTICS.
OUTLOOK THERAPEUTICS Implied Volatility | 2.8 |
OUTLOOK THERAPEUTICS's implied volatility exposes the market's sentiment of OUTLOOK THERAPEUTICS INC stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if OUTLOOK THERAPEUTICS's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that OUTLOOK THERAPEUTICS stock will not fluctuate a lot when OUTLOOK THERAPEUTICS's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in OUTLOOK THERAPEUTICS to buy its stock at a price that has no basis in reality. In that case, they are not buying OUTLOOK because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
OUTLOOK THERAPEUTICS after-hype prediction price | USD 0.44 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current OUTLOOK contract
Based on the Rule 16, the options market is currently suggesting that OUTLOOK THERAPEUTICS INC will have an average daily up or down price movement of about 0.18% per day over the life of the 2026-05-15 option contract. With OUTLOOK THERAPEUTICS trading at USD 0.42, that is roughly USD 7.35E-4 . If you think that the market is fully incorporating OUTLOOK THERAPEUTICS's daily price movement you should consider acquiring OUTLOOK THERAPEUTICS INC options at the current volatility level of 2.8%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out OUTLOOK THERAPEUTICS Basic Forecasting Models to cross-verify your projections. OUTLOOK THERAPEUTICS After-Hype Price Density Analysis
As far as predicting the price of OUTLOOK THERAPEUTICS at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in OUTLOOK THERAPEUTICS or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of OUTLOOK THERAPEUTICS, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
OUTLOOK THERAPEUTICS Estimiated After-Hype Price Volatility
In the context of predicting OUTLOOK THERAPEUTICS's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on OUTLOOK THERAPEUTICS's historical news coverage. OUTLOOK THERAPEUTICS's after-hype downside and upside margins for the prediction period are 0.02 and 10.43, respectively. We have considered OUTLOOK THERAPEUTICS's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
OUTLOOK THERAPEUTICS is abnormally volatile at this time. Analysis and calculation of next after-hype price of OUTLOOK THERAPEUTICS INC is based on 3 months time horizon.
OUTLOOK THERAPEUTICS Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as OUTLOOK THERAPEUTICS is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading OUTLOOK THERAPEUTICS backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with OUTLOOK THERAPEUTICS, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.13 | 9.99 | 0.02 | 0.14 | 11 Events / Month | 2 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.42 | 0.44 | 4.76 |
|
OUTLOOK THERAPEUTICS Hype Timeline
OUTLOOK THERAPEUTICS INC is now traded for 0.42. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of 0.14. OUTLOOK is expected to increase in value after the next headline, with the price projected to jump to 0.44 or above. The average volatility of media hype impact on the company the price is over 100%. The price upswing on the next news is projected to be 4.76%, whereas the daily expected return is now at -1.13%. The volatility of related hype on OUTLOOK THERAPEUTICS is about 7928.57%, with the expected price after the next announcement by competition of 0.56. OUTLOOK THERAPEUTICS INC currently holds about 26.02 M in cash with (51.83 T) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. Given the investment horizon of 90 days the next expected press release will be in about 11 days. Check out OUTLOOK THERAPEUTICS Basic Forecasting Models to cross-verify your projections.OUTLOOK THERAPEUTICS Related Hype Analysis
Having access to credible news sources related to OUTLOOK THERAPEUTICS's direct competition is more important than ever and may enhance your ability to predict OUTLOOK THERAPEUTICS's future price movements. Getting to know how OUTLOOK THERAPEUTICS's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how OUTLOOK THERAPEUTICS may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GOVX | GeoVax Labs | 0.65 | 8 per month | 0.00 | (0.28) | 9.38 | (13.70) | 42.89 | |
| BLRX | BioLineRx | 0.07 | 6 per month | 0.00 | (0.08) | 4.95 | (5.26) | 13.04 | |
| THAR | Tharimmune | (0.15) | 9 per month | 5.94 | 0.05 | 11.15 | (10.08) | 29.73 | |
| AIMD | Ainos Inc | 0.06 | 9 per month | 0.00 | (0.11) | 12.30 | (10.43) | 38.73 | |
| LPCN | Lipocine | 0.00 | 6 per month | 3.28 | 0.30 | 15.95 | (7.33) | 33.09 |
OUTLOOK THERAPEUTICS Additional Predictive Modules
Most predictive techniques to examine OUTLOOK price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for OUTLOOK using various technical indicators. When you analyze OUTLOOK charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About OUTLOOK THERAPEUTICS Predictive Indicators
The successful prediction of OUTLOOK THERAPEUTICS stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as OUTLOOK THERAPEUTICS INC, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of OUTLOOK THERAPEUTICS based on analysis of OUTLOOK THERAPEUTICS hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to OUTLOOK THERAPEUTICS's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to OUTLOOK THERAPEUTICS's related companies. | 2025 | 2026 (projected) | Dividend Yield | 70.3K | 73.8K | Price To Sales Ratio | 3.0E-5 | 2.9E-5 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out OUTLOOK THERAPEUTICS Basic Forecasting Models to cross-verify your projections. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. Anticipated expansion of OUTLOOK directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive OUTLOOK THERAPEUTICS assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.86) | Revenue Per Share | Quarterly Revenue Growth 6.583 | Return On Assets | Return On Equity |
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between OUTLOOK THERAPEUTICS's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding OUTLOOK THERAPEUTICS should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, OUTLOOK THERAPEUTICS's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.